文拉法辛联合认知行为治疗对惊恐障碍患者述情障碍的疗效分析  

Analysis of curative effect by venlafaxine combined with cognitive-behavioral therapy for alexithymia in panic disorder patients

作　　者：蔡松涛[1] 何莲珠[1] 陈平周[1] 胡晓虹[1] 

机构地区：[1]汕头大学精神卫生中心,515065

出　　处：《中国实用医药》2016年第16期23-24,共2页China Practical Medicine

摘　　要：目的探讨文拉法辛联合认知行为治疗评估惊恐障碍患者述情障碍的临床疗效。方法 97例惊恐障碍患者随机分为治疗组49例(文拉法辛联合认知行为治疗)与对照组48例(文拉法辛治疗),比较两组治疗后学业拖延量表(PASS)评分、多伦多述情障碍量表(TAS)总分和因子评分的差异。结果治疗第2、4、6、8周两组PASS评分均较治疗前下降(P<0.05),且治疗组PASS评分较对照组明显降低(P<0.05);治疗组治疗后TAS总分和因子2得分均比治疗前及对照组治疗后明显降低(P<0.05)。结论文拉法辛联合认知行为治疗对述情障碍有显著疗效,可供参考。Objective To investigate clinical effect by venlafaxine combined with cognitive-behavioral therapy for alexithymia in panic disorder patients. Methods A total of 97 panic disorder patients were randomly divided into treatment group with 49 cases（venlafaxine combined with cognitive-behavioral therapy） and control group with 48 cases（venlafaxine for treatment）. Comparison was made on academic procrastination scale（PASS） scores, Toronto alexithymia scale（TAS） total and item scores between the two groups after treatment. Results In 2, 4, 6, 8 weeks of treatment, both groups had lower PASS scores than those before treatment（P0.05）, and the treatment group had more obvious reduced PASS score than the control group（P0.05）. The treatment group had all lower total TAS score and item 2 score after treatment than those before treatment and those in the control group after treatment（P0.05）. Conclusion Combination of venlafaxine and cognitive-behavioral therapy provides precisely curative effect for panic disorder, and it can be taken as reference.

关 键 词：惊恐障碍 认知行为治疗 文拉法辛 述情障碍 

分 类 号：R749.7[医药卫生—神经病学与精神病学]